University of California San Francisco

Biography

Milad Rezvani, M.D. studied Medicine in Hannover/Germany and Freiburg/Germany and also worked as a volunteer in numerous Primary Health Care projects in Ghana, Nepal, Peru and Argentina. As a graduate student he investigated the effect of genetic variants in endoderm and lung development on neonatal lung diseases. As an exchange student he came to UCSF to work on generating therapeutic human liver cells from readily available skin cells. As a Postdoctoral Fellow of the German Research Foundation he continued working in the Willenbring lab to develop potential therapies for chronic liver diseases, particularly by in vivo reprogramming of cirrhosis-causing myofibroblasts into hepatocytes.

Education

Education

Wilhelm-Raabe-Schule, Lower Saxony, Hannover, Germany, University-entrance diploma, 2004

 

Hannover Medical School, Germany, Preclinical Medical Examination, 2006

 

University of Freiburg, Germany, German Medical State Examination, 2011

 

04/2015 - 08/2016 Clinical guest student at USCF Medical Center at Mission Bay, Pediatric Hepatology and San Francisco General Hospital, Adult GI division

 

University of Freiburg, Germany, Doctoral Dissertation, "Role of Matrix Metalloproteinases in the genetics of Bronchopulmonary Dysplasia and Neonatal Respiratory Distress Syndrome", 2013

 

Biomedical Exchange Program (BMEP)-Scholarship funded by the German Academic Exchange Service (DAAD) for research on liver cell therapy at the Willenbring lab at the University of California San Francisco (UCSF), 2012-2013

Fellowships

Biomedical Exchange Program (BMEP)-Scholarship funded by the German Academic Exchange Service (DAAD), Research Fellowship of the German Research Foundation

Postdoctoral Training

Willenbring laboratory, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, UCSF, Research Foci: 1. Therapeutic liver repopulation with hepatocytes generated from human fibroblasts, 2. In vivo hepatic reprogramming of myofibroblasts in liver fibrosis and cirrhosis

Clinical Interests

Adult and pediatric Hepatology and Gastroenterology

11/2015: Presidential Plenary Session of the The Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, CA, selected oral presentation: “In vivo reprogramming of myofibroblasts into hepatocytes as a therapy for liver fibrosis”

Research Interests

Liver Regeneration

Stem Cells

Liver Cell Therapy

Liver Fibrosis

Cirrhosis

Biliary Diseases

Genetics

Gene Therapy

Gene Vectors

Dysplasia

Metaplasia

Barrett's Esophagus

Lung Development
Lung Diseases

Lung Fibrosis

Bronchopulmonary Dysplasia